HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC. - Mei, Jie; Jiang, Guanyu; Chen, Yundi; Xu, Yongrui; Wan, Yuan; Chen, Ruo; Liu, Feng; Mao, Wenjun; Zheng, Mingfeng; Xu, Junying (BMC Cancer, 2022)